- Report
- July 2023
- 145 Pages
Global
From €3028EUR$3,150USD£2,596GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- December 2023
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- December 2023
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- April 2023
- 75 Pages
Global
From €3604EUR$3,750USD£3,091GBP
- Report
- May 2020
- 124 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- July 2020
- 156 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- June 2020
- 215 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- January 2022
- 200 Pages
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- July 2022
- 100 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- February 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- December 2021
- 188 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- February 2021
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- April 2023
- 122 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- February 2022
- 123 Pages
Global
From €4277EUR$4,450USD£3,668GBP
- Report
- June 2021
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- August 2020
- 30 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- December 2018
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- December 2018
Global
From €7209EUR$7,500USD£6,182GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$3,901USD£3,106GBP
Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more